2Chung Y L, Lee M Y, Wang A J, et al. A therapeutic strat- egy uses histone deacetylade inhibitors to modulate the ex- pression of genes involved in the pathogenesis of rheuma- toid arthritis [ J ]. Mol Ther,2003, ( 8 ) : 707 - 717.
3Whetstine JR, Ceron J, Ladd B, et al. Regulation of tissue - specific and extracellular matrix related genes by a class 1 histone deacetylase [ J]. Mol Cell, 2005, (18) : 483 - 490.
4Sawa H, Murakami H, Ohshima Y, et al. Histone deacety- lase inhibitors such as sodium butyrate and trichostatin a inhibit vascular endothelial growth factor(VEGF) secretion from human ghoblastoma cells [ J ]. Brain Tumor Pathol, 2002, (19) :77 -81.
5Simooka H, Oyama T, Sano T, et al. lmmunohistochemical analysis of 14 - 3 - 3sigma and related proteins in hyper- plastic and neplastic breast lesions, with particular refer- ence to early carcinogenesis [ J ]. Lung Cancer, 2005,47 (2) :225 -233.
6Tian H,Faje A T,Lee SL,et al. Radiation -induced phos- phorylation of Chkl at $345 is associated with p53 - de- pendent cell cycle arrest pathways [ J ]. Neoplasia, 2002,4 (2) :264 -269.
7Lehmann - Che J, Andre F, Desmedt C, et al. Cyclophos- phamide dose intensification may circumvent anthracycline resistance of P53 mutant breast cancers [ J ]. Oncologist, 2010,15 (3) :246 - 252.
8Bouwan P,Aly A, Escandell JM, et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple - negative and BRCA - mutated breast cancers [ J ]. Nat Struct Mol Biol, 201 O, 17 (6) : 688 - 695.
9Mutze K, Langer R, Becker K, et al. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer[ J ]. Ann Surg Oncol,2010,17 (12) 3336 - 3343.
10Hwang J J, Kim YS, Kim M J, et al. A novel histone deacety- lase inhibitor, CG0066, induces cell death through both ex- trinsic and intrinsic apoptotic pathways [ J ]. Antieancer Drugs ,2009,20(9) 815 - 821.
